全文获取类型
收费全文 | 1018132篇 |
免费 | 76272篇 |
国内免费 | 8564篇 |
专业分类
耳鼻咽喉 | 13598篇 |
儿科学 | 25176篇 |
妇产科学 | 24191篇 |
基础医学 | 143263篇 |
口腔科学 | 29812篇 |
临床医学 | 93326篇 |
内科学 | 195977篇 |
皮肤病学 | 19918篇 |
神经病学 | 77328篇 |
特种医学 | 39900篇 |
外国民族医学 | 135篇 |
外科学 | 160124篇 |
综合类 | 33280篇 |
现状与发展 | 23篇 |
一般理论 | 247篇 |
预防医学 | 67457篇 |
眼科学 | 24226篇 |
药学 | 81566篇 |
105篇 | |
中国医学 | 7961篇 |
肿瘤学 | 65355篇 |
出版年
2021年 | 10715篇 |
2019年 | 9100篇 |
2018年 | 12340篇 |
2017年 | 9857篇 |
2016年 | 10536篇 |
2015年 | 13099篇 |
2014年 | 17182篇 |
2013年 | 21886篇 |
2012年 | 30505篇 |
2011年 | 32491篇 |
2010年 | 19297篇 |
2009年 | 17784篇 |
2008年 | 29069篇 |
2007年 | 30049篇 |
2006年 | 31013篇 |
2005年 | 29989篇 |
2004年 | 27244篇 |
2003年 | 26225篇 |
2002年 | 25314篇 |
2001年 | 56543篇 |
2000年 | 58485篇 |
1999年 | 49012篇 |
1998年 | 12144篇 |
1997年 | 10806篇 |
1996年 | 10678篇 |
1995年 | 9923篇 |
1994年 | 9108篇 |
1993年 | 8117篇 |
1992年 | 36066篇 |
1991年 | 34396篇 |
1990年 | 33177篇 |
1989年 | 32271篇 |
1988年 | 29324篇 |
1987年 | 28527篇 |
1986年 | 26501篇 |
1985年 | 25306篇 |
1984年 | 17910篇 |
1983年 | 15186篇 |
1982年 | 7832篇 |
1979年 | 15802篇 |
1978年 | 10598篇 |
1977年 | 9052篇 |
1976年 | 7871篇 |
1975年 | 8628篇 |
1974年 | 10466篇 |
1973年 | 9858篇 |
1972年 | 9357篇 |
1971年 | 8852篇 |
1970年 | 8426篇 |
1969年 | 7923篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Hassen Lena M. Albarrak Rana A. Albahlal Reem A. Alsaqabi Dimah K. Hassen Ikhlass M. Daghestani Maha H. Alqurtas Eman M. Alkhalaf Abdulaziz T. Bedaiwi Mohammed K. Omair Mohammed A. Almaghlouth Ibrahim A. 《Quality of life research》2022,31(11):3229-3239
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional... 相似文献
2.
Bortezomib is a novel proteasome inhibitor, which has been successfully used to treat mantle cell lymphoma and multiple myeloma. However, the direct effects of bortezomib on acute promyelocytic leukaemia (APL) have not been fully investigated. In the present study, the WST-8 assay, western blotting, flow cytometry, monodansylcadaverine staining and transmission electron microscopy were performed. It was demonstrated that bortezomib treatment induced a time- and dose-dependent decrease in the viability of NB4 cells. Bortezomib treatment induced cell apoptosis in NB4 cells, as assessed by Annexin V/propidium iodide analysis, and the detection of cleaved caspase-3, cleaved poly(ADP-ribose) polymerase, Bax and Bcl-2 expression. Furthermore, bortezomib treatment induced autophagy in NB4 cells, as indicated by autophagosome formation, p62 degradation, LC3-I to LC3-II conversion and formation of acidic autophagic vacuoles. Notably, autophagy induced by bortezomib was initiated prior to apoptosis. Inhibition of autophagy by knocking down Beclin-1 expression increased bortezomib-induced apoptosis in NB4 cells. Therefore, the present study revealed that the combination of bortezomib and autophagy inhibition may be a potential treatment strategy for APL. 相似文献
3.
“三全育人”视角下思政教育机制实践与探索——“杏林成长导师”计划的构建 《医学教育管理》2021,7(6):656-660
“三全育人”是高校思政教育工作的关键一环,也是中医药高校推动思政教育的重要内容。以“三全育人”为视角对北京中医药大学思想政治教育举措“杏林成长导师”计划路径、内容深入分析,运用统计分析和文献研究方法,剖析该计划对中医学专业大学生的学业、思想和实践等多个层面的现实成效,从而为“三全育人”理念在中医药院校制度建构中的应用提供新的视角与方法。 相似文献
4.
患者男,74岁,主因尿频、尿急、排尿困难10余年,加重1个月,患者因脑梗死后遗症康复治疗于2018年8月1日就诊于天津中医药大学第一附属医院针灸科。查颅脑MR:未见新发梗死灶。患者10余年前发现尿频、尿急、尿不尽、夜尿多等症状,曾诊断“良性前列腺增生”,未经系统诊治。 相似文献
5.
6.
Stepanova E. S. Makarenkova L. M. Chistyakov V. V. Rybakov Yu. L. Gukasov V. M. Fedotcheva T. A. Parshin V. A. Votyakov V. A. Shimanovskii N. L. 《Pharmaceutical Chemistry Journal》2019,52(12):1016-1020
Pharmaceutical Chemistry Journal - An HPLC-MS method for simultaneous quantitative determination of a novel gestagenic pharmaceutical and two of its metabolites in rat and rabbit blood sera was... 相似文献
7.
Elizabeth D. Krebs Robert B. Hawkins J. Hunter Mehaffey Clifford E. Fonner Alan M. Speir Mohammed A. Quader Jeffrey B. Rich Leora T. Yarboro Nicholas R. Teman Gorav Ailawadi 《The Journal of thoracic and cardiovascular surgery》2019,157(4):1533-1542.e2
Objectives
Expedient extubation after cardiac surgery has been associated with improved outcomes, leading to postoperative extubation frequently during overnight hours. However, recent evidence in a mixed medical-surgical intensive care unit population demonstrated worse outcomes with overnight extubation. This study investigated the impact of overnight extubation in a statewide, multicenter Society of Thoracic Surgeons database.Methods
Records from 39,812 patients undergoing coronary artery bypass grafting or valve operations (2008-2016) and extubated within 24 hours were stratified according to extubation time between 06:00 and 18:00 (day) or between 18:00 and 6:00 (overnight). Outcomes including reintubation, mortality, and composite morbidity-mortality were evaluated using hierarchical regression models adjusted for Society of Thoracic Surgeons predictive risk scores. To further analyze extubation during the night, a subanalysis stratified patients into 3 groups: 06:00 to 18:00, 18:00 to 24:00, and 24:00 to 06:00.Results
A total of 20,758 patients were extubated overnight (52.1%) and were slightly older (median age 66 vs 65 years, P < .001) with a longer duration of ventilation (4 vs 7 hours, P < .001). Day and overnight extubation were associated with equivalent operative mortality (1.7% vs 1.7%, P = .880), reintubation (3.7% vs 3.4%, P = .141), and composite morbidity-mortality (8.2% vs 8.0%, P = .314). After risk adjustment, overnight extubation was not associated with any difference in reintubation, mortality, or composite morbidity-mortality. On subanalysis, those extubated between 24:00 and 06:00 exhibited increased composite morbidity-mortality (odds ratio, 1.18; P = .001) but no difference in reintubation or mortality.Conclusions
Extubation overnight was not associated with increased mortality or reintubation. These results suggest that in the appropriate clinical setting, it is safe to routinely extubate cardiac surgery patients overnight. 相似文献8.
9.